Esperion (ESPR) with two different buys from President/CEO Timothy Mayleben over the past week, a $243K buy on 3/14 at $48.73 and a $217K buy on 3/20 at $43.48. Mayleben has been with ESPR since its acquisition by Pfizer in 2004 and then CEO of Veric...